Literature DB >> 9381432

Surfactant medication for acute respiratory distress syndrome.

S V Baudouin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9381432      PMCID： PMC1765883          DOI： 10.1136/thx.52.2008.s9

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  27 in total

1.  A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group.

Authors:  L Gattinoni; L Brazzi; P Pelosi; R Latini; G Tognoni; A Pesenti; R Fumagalli
Journal:  N Engl J Med       Date:  1995-10-19       Impact factor: 91.245

2.  Surfactant replacement therapy in ARDS: white knight or noise in the system?

Authors:  T E Nicholas; I R Doyle; A D Bersten
Journal:  Thorax       Date:  1997-02       Impact factor: 9.139

Review 3.  Evolving concepts in the pathogenesis of postinjury multiple organ failure.

Authors:  F A Moore; E E Moore
Journal:  Surg Clin North Am       Date:  1995-04       Impact factor: 2.741

4.  Early application of positive end-expiratory pressure in patients at risk for the adult respiratory-distress syndrome.

Authors:  P E Pepe; L D Hudson; C J Carrico
Journal:  N Engl J Med       Date:  1984-08-02       Impact factor: 91.245

5.  Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.

Authors:  A H Morris; C J Wallace; R L Menlove; T P Clemmer; J F Orme; L K Weaver; N C Dean; F Thomas; T D East; N L Pace; M R Suchyta; E Beck; M Bombino; D F Sittig; S Böhm; B Hoffmann; H Becks; S Butler; J Pearl; B Rasmusson
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

6.  Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study.

Authors:  W M Zapol; M T Snider; J D Hill; R J Fallat; R H Bartlett; L H Edmunds; A H Morris; E C Peirce; A N Thomas; H J Proctor; P A Drinker; P C Pratt; A Bagniewski; R G Miller
Journal:  JAMA       Date:  1979-11-16       Impact factor: 56.272

7.  Elevation of systemic oxygen delivery in the treatment of critically ill patients.

Authors:  M A Hayes; A C Timmins; E H Yau; M Palazzo; C J Hinds; D Watson
Journal:  N Engl J Med       Date:  1994-06-16       Impact factor: 91.245

8.  Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial.

Authors:  E Abraham; Y C Park; P Covington; S A Conrad; M Schwartz
Journal:  Crit Care Med       Date:  1996-01       Impact factor: 7.598

9.  High-frequency jet ventilation. A prospective randomized evaluation.

Authors:  G C Carlon; W S Howland; C Ray; S Miodownik; J P Griffin; J S Groeger
Journal:  Chest       Date:  1983-11       Impact factor: 9.410

Review 10.  Neutrophil-mediated tissue injury and its modulation.

Authors:  S Fujishima; N Aikawa
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440
View more
  4 in total

Review 1.  Ventilator induced lung injury and infection in the critically ill.

Authors:  S V Baudouin
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 2.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

Review 3.  Acute lung injury and acute respiratory distress syndrome.

Authors:  Anil Vasudevan; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2004-08       Impact factor: 1.967

Review 4.  Adult respiratory distress syndrome.

Authors:  S Cutts; R Talboys; C Paspula; E M Prempeh; R Fanous; D Ail
Journal:  Ann R Coll Surg Engl       Date:  2016-08-11       Impact factor: 1.951
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.